(function(){var loadHandler=window['sl_{656BC694-C0A1-4D3A-883A-292145561588}'];loadHandler&&loadHandler(1, '<div id="spr0_3a3ac4d"><div id="spr1_3a3ac4d" class="kern slide"><img id="img0_3a3ac4d" src="data/img5.png" width="1280px" height="720px" alt="" style="left:0px;top:0px;"/><div id="svg6_3a3ac4d" style="left:49.06px;top:94.123px;"><svg width="1182" height="3" viewBox="-1.333 -0.667 1182 3"><g fill="#c2b6ab" stroke="none"><path stroke="#c2b6ab" stroke-width="1.333" stroke-linecap="butt" transform="translate(-50.393677,-94.789497)" d="M50.394,95.456 H1229.606"/></g></svg></div><div id="svg9_3a3ac4d" style="left:49.06px;top:94.123px;"><svg width="1182" height="3" viewBox="-1.333 -0.667 1182 3"><g fill="#cdd7dc" stroke="none"><path stroke="#cdd7dc" stroke-width="1.333" stroke-linecap="butt" transform="translate(-50.393677,-94.789497)" d="M50.394,95.456 H1229.606"/></g></svg></div></div><div id="spr2_3a3ac4d" class="kern slide"><div id="spr3_3a3ac4d" style="left:50.394px;top:18.898px;"><div style="width:0px;"><span id="txt0_3a3ac4d" data-width="126.104172" style="top:-0.696px;">Outline</span></div></div><div id="spr4_3a3ac4d" style="left:50.394px;top:114.354px;"><div style="width:0px;"><span id="txt1_3a3ac4d" data-width="511.744781" style="top:1.899px;">Economic evaluation of personalised medicine</span></div><div style="width:0px;"><span id="txt2_3a3ac4d" class="nokern relpos" dir="auto" style="left:28.333px;top:42.623px;">•</span> <span id="txt3_3a3ac4d" class="relpos" data-width="372.955719" style="left:47.331px;top:42.747px;">What is personalised medicine?</span></div><div style="width:0px;"><span id="txt4_3a3ac4d" class="nokern relpos" dir="auto" style="left:28.333px;top:81.023px;">•</span> <span id="txt5_3a3ac4d" class="relpos" data-width="474.739563" style="left:47.331px;top:81.147px;">Brief outline of the HEcoPerMed project</span></div><div style="width:0px;"><span id="txt6_3a3ac4d" class="nokern relpos" dir="auto" style="left:28.333px;top:119.423px;">•</span> <span id="txt7_3a3ac4d" class="relpos" data-width="741.236938" style="left:47.331px;top:119.547px;">Guidance on the economic evaluation of personalised medicine</span></div><div style="width:0px;"><span id="txt8_3a3ac4d" class="nokern relpos" dir="auto" style="left:28.333px;top:157.823px;">•</span> <span id="txt9_3a3ac4d" class="relpos" data-width="988.723938" style="left:47.331px;top:157.947px;">Case study of upfront DPYD testing for metastatic breast cancer patients assigned to</span></div><div style="width:0px;"><span id="txt10_3a3ac4d" data-width="210.364578" style="left:56.667px;top:196.347px;">capecitabine/5FU</span></div><div style="width:0px;"><span id="txt11_3a3ac4d" data-width="459.739563" style="top:270.699px;">Reimbursement of personalised medicine</span></div><div style="width:0px;"><span id="txt12_3a3ac4d" class="nokern relpos" dir="auto" style="left:28.333px;top:311.423px;">•</span> <span id="txt13_3a3ac4d" class="relpos" data-width="315.364563" style="left:54.997px;top:311.547px;">Models for reimbursement</span></div><div style="width:0px;"><span id="txt14_3a3ac4d" class="nokern relpos" dir="auto" style="left:28.333px;top:349.823px;">•</span> <span id="txt15_3a3ac4d" class="relpos" data-width="430.416656" style="left:54.997px;top:349.947px;">Barriers to reimbursement &amp; actions</span></div><div style="width:0px;"><span id="txt16_3a3ac4d" data-width="124.205727" style="top:424.299px;">Conclusion</span></div></div></div></div>', '{"s":[]}');})();